2017-07-20

On the afternoon of July the 6th, leaders from the Ministry of Health of BRICS countries,who were participating in the BRICS Health Ministers Conference and High Level Meeting on Traditional Medicine held in Tianjin, accompanied by Vice Director of China's National Health and Family Planning Ministry Cui Li,paid a visit to Tasly.

Dantonic ( knows as Compound Danshen Dripping Pill in China ), one of Tasly's key traditional medicines, which has completed the FDA Ⅲ clinical experiment, is the first compound traditional medicine in the world to complete overseas clinical research in the 3rd phase. In the production base of dripping pill, Yan Xijun, Chairman of the Board of Tasly Holding Group, introduced the world first high-speed dripping-pill manufacturing machine, which was researched and developed by Tasly independently, to the guests. The machine can produce tiny dripping pill which is able to be loaded in the capsule form. Therefore, it helps Dantonic, which is in capsule form, maintain the advantage of solid dispersion of dripping pill, according to Chairman Yan's introduction.

In the experience pavilion of Tasly Great-health Exhibition Hall, an equipment, researched and developed by Tasly Phar. Co., Ltd, which can assist in TCM diagnoses and arrange the health management of patients, attracted the guests' attention. Vice General Minister of Ministry of Health of South Africa Samzamban Pillai highly praised it and said that he had been thinking diagnoses in TCM still relied on feeling the pulse and never imagined that TCM had developed with modern technology so closely.

As the cherished treasure of Chinese culture, TCM is the key for foreigners to learn about Chinese cultivation . Owing to this visit to Tasly, ministers of the Health Ministry from BRICS countries not only saw the achievement made by Tasly in TCM internationalization but also know more about TCM.

According to the earlier news, the Secretary of Tianjin Municipal Committee Li Hongzhong also mentioned the success of Dantonic T89(Danshen Dripping Pill) to complete FDA Ⅲ clinical experiment in his speech at the opening ceremony of the Conference. Vice President of Tasly Holding Group Wu Danyong attended the conference and visited distinguished guests including ministers, experts and scholars during the meeting.

Tasly Pharmaceutical Group Co. Ltd. published this content on 20 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 July 2017 08:08:04 UTC.

Original documenthttp://en.tasly.com/show-164-6793-1.html

Public permalinkhttp://www.publicnow.com/view/61D5AE0165D545477EBDF47550B3F22EE8A7A3D8